EVMN
Evommune, Inc.
8.80$
-8.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | – | – | 100.0% | – | 100.0% | – | – | – | 100.0% | |
| 3.9% | – | – | – | 12.6% | – | 3.1% | – | – | – | – | |
| 96.1% | – | – | – | 87.4% | – | 100.0% | – | – | – | – | |
| 113.5% | – | – | – | 478.7% | – | 196.4% | – | – | – | 837.7% | |
| – | – | – | – | – | – | 36.9% | – | – | – | 259.8% | |
| 149.8% | – | – | – | 588.5% | – | 233.3% | – | – | – | 1,115.4% | |
| -53.6% | – | – | – | -501.1% | – | -133.3% | – | – | – | -1,018.9% | |
| 0.2% | – | – | – | 0.1% | – | – | – | – | – | – | |
| -39.8% | – | – | – | -485.2% | – | -124.8% | – | – | – | -946.7% | |
| -39.8% | – | – | – | -485.2% | – | -124.8% | – | – | – | -946.7% | |
| -35.7% | – | – | – | -472.5% | – | -121.6% | – | – | – | -957.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.